Potential of Novel EPO Derivatives in Limb Ischemia
Erythropoietin (EPO) has tissue-protective properties, but it increases the risk of thromboembolism by raising the haemoglobin concentration. New generation of EPO derivatives is tissue protective without the haematopoietic side effects. Preclinical studies have demonstrated their effectiveness and...
Saved in:
Main Authors: | Dhiraj Joshi, Janice Tsui, Rebekah Yu, Xu Shiwen, Sadasivam Selvakumar, David J. Abraham, Daryll M. Baker |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2012-01-01
|
Series: | Cardiology Research and Practice |
Online Access: | http://dx.doi.org/10.1155/2012/213785 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Stromal-Cell-Derived Factor-1 (SDF-1)/CXCL12 as Potential Target of Therapeutic Angiogenesis in Critical Leg Ischaemia
by: Teik K. Ho, et al.
Published: (2012-01-01) -
Dose Effect Evaluation and Therapeutic Window of the Neuro-EPO Nasal Application for the Treatment of the Focal Ischemia Model in the Mongolian Gerbil
by: Iliana Sosa Teste, et al.
Published: (2012-01-01) -
Cell Therapy in Patients with Critical Limb Ischemia
by: Rita Compagna, et al.
Published: (2015-01-01) -
Our Treatment Strategy for Critical Limb Ischemia
by: Tetsuo Yamada, et al.
Published: (2013-01-01) -
Emerging Strategies for Revascularization: Use of Cell-Derived Extracellular Vesicles and Artificial Nanovesicles in Critical Limb Ischemia
by: Vijay Murali Ravi Mythili, et al.
Published: (2025-01-01)